Logotype for Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals (REGN) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Regeneron Pharmaceuticals Inc

Proxy filing summary

24 Apr, 2026

Voting matters and shareholder proposals

  • Election of five directors: Joseph L. Goldstein, Christine A. Poon, David P. Schenkein, Craig B. Thompson, and Huda Y. Zoghbi, with board recommending a vote for each.

  • Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026.

  • Advisory vote to approve compensation of Named Executive Officers, with board recommending approval.

  • Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends all director nominees for election at the 2026 Annual Meeting.

Executive compensation and say-on-pay

  • Advisory vote on executive compensation is included, with board recommending approval.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more